Skip to main content

JPMORGAN CHASE & CO

Position in NEO — Neogenomics Inc

CIK 19617 NEW YORK, NY

Position in NEO

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$4,494,017
-$2,374,233 QoQ
Shares Held
605,663
+3.7% QoQ
Ownership
0.465%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 81% Shared 0% None 19%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $13,314,994,703 across 38 Diagnostics & Research names. NEO ranks #23 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,494,017 605,663
2025-12-31 $6,868,250 584,035
2025-09-30 $6,318,307 818,434
2025-06-30 $3,415,237 467,201
2025-03-31 $2,728,778 287,543
2024-12-31 $10,008,828 607,332
2024-09-30 $6,480,367 439,347
2024-06-30 $16,907,790 1,219,019
2024-03-31 $15,395,710 979,371
2023-12-31 $12,875,022 795,737
2023-09-30 $13,660,169 1,110,583
2023-06-30 $18,155,417 1,129,771
2023-03-31 $20,863,705 1,198,375
2022-12-31 $13,907,278 1,505,117
2022-09-30 $9,188,650 1,067,207
2022-06-30 $2,051,093 251,668
2022-03-31 $1,592,280 131,052
2021-12-31 $3,877,428 113,641
2021-09-30 $3,960,020 82,090
2021-06-30 $9,230,305 204,346
2021-03-31 $15,623,623 323,940
2020-12-31 $18,304,466 339,979
2020-09-30 $11,934,723 323,522
2020-06-30 $9,460,052 305,360
2020-03-31 $2,534,927 91,812